Trending
- World Bank rolls out plan to slash EAC internet costs, fuel regional trade
- Kenya’s fertilizer distribution reforms cut consumption by 172,000 tonnes
- JPMorgan CEO to scout for loan and corporate deals in Africa tour—analysts
- The science is clear. The world is far off track from achieving vital climate goals
- Energy transition: Why Africa’s race to net-zero is moving too slowly
- Nigeria inflation cools in August, but analysts warn dip could be short-lived
- Africa’s race against time: Why climate adaptation can’t wait
- Fertilizer giant OCP Group and IFC sign $108M deal to tackle Morocco’s water crisis
Browsing: Dr Adesina
- The African pharmaceuticals market is projected to reach $34 billion by 2027.
- Egypt has been tipped to contribute most to Africa’s pharmaceutical industry’s growth.
- What implication does this change present to global pharmaceutical giants?
Africa pharmaceutical investment is well underway, and for the first time, the continent seeks to produce and distribute medicinal drugs but, what would be the impact on the global industry? “The failures of the global health systems during the COVID-19 pandemic—when export restrictions, lockdowns, and hoarding sent supply chains into frantic disarray—made local manufacturing of pharmaceutical supplies a top priority for African leaders,” notes global health writer Sara Jerving in her report titled New foundation is ready to help African pharmaceutical manufacturers.
Africa pharmaceuticals market reached $25 billion 2022 and is expected to grow at a 6 percent five-year CAGR to reach $34 billion by 2027 reports IQVIA, a global research institute. According to the …